pentobarbital will decrease the level or outcome of guanfacine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Check Intently. Solid or reasonable CYP3A4 inducers considerably lower guanfacine plasma concentrations and elimination 50 percent-existence.pentobarbital will decrease the level or influence of repaglinide by affe